Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share News

123456789

DIRECTOR DEALINGS: Allergy Therapeutics Non-Executive Lifts Stake

16th Mar 2018 17:30

LONDON (Alliance News) - Pharmaceutical company Allergy Therapeutics PLC said Friday Non-Executive Director Tunde Otulana acquired shares on Thursday.Otulana acquired a Read More

Allergy Therapeutics Profit Falls On Costs As Pivotal Year Looms

7th Mar 2018 13:42

LONDON (Alliance News) - Allergy Therapeutics PLC said Wednesday half year profit fell due to higher research and development costs, as the company prepares for 2018 clinical Read More

Allergy Therapeutics' House-Dust Mite Allergy Vaccine Trial Approved

14th Feb 2017 08:49

Read More

Allergy Therapeutics Granted EU Patent For Microcrystalline Tyrosine

2nd Nov 2016 09:29

Read More

DIRECTOR DEALINGS: Allergy Therapeutics Chairman Lifts Stake

29th Sep 2016 11:55

Read More

DIRECTOR DEALINGS: Allergy Therapeutics Finance Boss Buys First Shares

28th Sep 2016 10:41

Read More

Allergy Therapeutics Expects Revenue Rise Despite Euro Weakening

13th Jul 2016 08:43

Read More

Allergy Therapeutics Welcomes Positive Follow-Up Results For Acarovac

8th Jul 2016 07:26

Read More

WINNERS & LOSERS SUMMARY: easyJet And Foxtons In Post-Brexit Warnings

27th Jun 2016 09:51

Read More

Allergy Therapeutics Sees Delayed US Market Launch For GrassMATAMPL

27th Jun 2016 09:06

Read More

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

10th Jun 2016 07:41

Read More

Allergy Therapeutics Gets Positive Birch Pollen Treatment Results

9th May 2016 06:57

Read More

NetScientic Poaches New Finance Boss From Allergy Therapeutics

5th Apr 2016 08:12

Read More

Allergy Therapeutics Finance Director Ian Postlethwaite Resigns

17th Mar 2016 09:08

Read More

BROKER RATINGS SUMMARY: Jefferies Starts Metro Bank With Buy Rating

10th Mar 2016 09:33

Read More

Allergy Therapeutics Profit Drops On Higher Costs As Revenue Edges Up

8th Mar 2016 10:59

Read More

Allergy Therapeutics Completes Enrolment For Grass Pollen Drug Study

18th Feb 2016 08:08

Read More

Allergy Therapeutics Revenue Up In First Half, Full Year Seen In Line

13th Jan 2016 09:38

Read More

Allergy Therapeutics Begins US Phase II Study Of Grass Allergy Vaccine

7th Dec 2015 07:54

Read More

Allergy Therapeutics Completes Patient Enrolment For Birch Study

30th Nov 2015 09:25

Read More

123456789
FTSE 100 Latest
Value8,809.74
Change53.53